FDA approves Merck’s Keytruda in combination with chemotherapy for advanced lung cancer treatment

The US Food and Drug Administration (FDA) has granted approval to Merck’s cancer immunotherapy, Keytruda (pembrolizumab), in combination with chemotherapy, as a first-line treatment option ... Read More